Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Still a Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares gapped up prior to trading on Tuesday. The stock had previously closed at $6.75, but opened at $7.17. Coloplast A/S shares last traded at $7.14, with a volume of 62,691 shares changing hands.

Coloplast A/S Stock Up 7.7%

The company has a debt-to-equity ratio of 1.51, a quick ratio of 0.94 and a current ratio of 1.56. The firm has a fifty day simple moving average of $6.82 and a 200-day simple moving average of $6.81. The firm has a market cap of $16.38 billion, a price-to-earnings ratio of 38.27, a P/E/G ratio of 2.56 and a beta of 0.21.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%. As a group, sell-side analysts expect that Coloplast A/S Sponsored ADR will post 0.40 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.

Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.